Lisanti Capital Growth’s Merit Medical Systems MMSI Stock Holding History

Lisanti Capital Growth’s Portfolio MMSI Stock Details MMSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,130	Closed	-$3.61M	–	127
2025 Q1	$3.61M	Buy	+34,130	New	+$3.52M	1.07%	39
2024 Q4	–	Sell	-8,545	Closed	-$845K	–	128
2024 Q3	$845K	Buy	+8,545	New	+$782K	0.21%	108
2023 Q3	–	Sell	-41,120	Closed	-$3.44M	–	153
2023 Q2	$3.44M	Buy	+41,120	New	+$3.34M	0.48%	89
2019 Q2	–	Sell	-89,485	Closed	-$5.53M	–	120
2019 Q1	$5.53M	Sell	89,485 -4,135	-4%	-$235K	1.96%	5
2018 Q4	$5.22M	Buy	93,620 +44,720	+91%	+$2.66M	2.11%	8
2018 Q3	$3M	Buy	48,900 +29,430	+151%	+$1.69M	1.04%	41
2018 Q2	$997K	Buy	19,470 +5,950	+44%	+$295K	0.38%	91
2018 Q1	$613K	Buy	+13,520	New	+$612K	0.3%	106

Other funds holding MMSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Lisanti Capital Growth's MMSI Position: Q2 2025 in Review

Lisanti Capital Growth sold out of Merit Medical Systems (MMSI) in Q2 2025, closing a stake of 34,130 shares — an estimated $3.61M sold.

Lisanti Capital Growth first reported a position in MMSI in Q1 2018 and held it in 8 quarters. The position peaked at $5.53M in Q1 2019. 379 funds tracked by Wall St. Rank hold MMSI as of Q2 2025.

Lisanti Capital Growth reported no remaining Merit Medical Systems position as of Q2 2025 after selling out during the quarter.
Lisanti Capital Growth sold 34,130 Merit Medical Systems shares in Q2 2025, an estimated $3.61M.
Lisanti Capital Growth first reported a position in Merit Medical Systems in Q1 2018 and held it in 8 quarters.
Lisanti Capital Growth's Merit Medical Systems position peaked at $5.53M in Q1 2019.
379 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2025.

Based on Lisanti Capital Growth's 13F filing for Q2 2025, filed 7 Aug 2025.